n Monday, the FDA approved Truvada, the first medication intended to prevent HIV infections in people having sex with infected partners. In clinical trials where HIV-negative individuals had unprotected sex with multiple partners, including some with HIV, the pill reduced the risk of infection by 42 percent compared with a placebo. Another trial with heterosexual couples where one partner was infected found that Truvada, which is taken daily, reduced the risk by 75 percent. The FDA warned that the drug, which will cost patients about $450 a year, should be used in conjunction with other prevention methods.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Why China's Communist Party is headed for collapse
- 31 TV shows to watch in 2014
- Why Texas Republicans may want to cool the anti-Obama land-grab talk
- He said he was leaving. She ignored him.
- Why the poor's investment of choice is so alarming
- How to make perfect fried rice in 6 easy steps
- What would a U.S.-Russia war look like?
- Why atheism doesn't have the upper hand over religion
- Obama doesn't have a manhood problem — but conservatives certainly do
- Why we need a maximum wage
Subscribe to the Week